Abstract:Delivering therapeutic agents efficiently to inflamed joints remains an intractable problem in rheumatoid arthritis (RA) treatment due to the complicated physiological barriers. Circulating monocytes could selec-tively migrate to inflamed sites and differentiate into resident macrophages to aggravate RA. Therefore, a drug carrier that can be specifically internalized by circulating monocytes and switch monocytes into anti-inflammatory phenotype when reaching inflamed sites, might bypass the in vivo physiological barri-ers and achieve efficient RA therapy. Herein, we design a dextran sulfate (DS) functionalized nanoparti-cle (ZDNP) to selectively deliver anti-inflammatory agent dexamethasone (Dex) to circulating monocytes via the scavenger receptors on monocytes. Monocytes engulfing drug-loaded ZDNP could subsequently home to arthritic joints and act as a "living drug depot" to combat RA. Results revealed that ZDNP could be preferentially internalized by circulating monocytes when intravenously administrated in vivo . In a rat arthritic model, we found that circulating monocytes remarkably facilitated drug distribution and re-tention in inflamed joints. Moreover, monocytes engulfing drug-loaded nanoparticles exhibited favorable anti-inflammatory ability and M2-biased differentiation. Our work offers a facile approach to achieve site -directed anti-inflammatory therapy by taking advantage of the inflammation-homing ability of circulating monocytes.Statement of significanceCirculating monocytes can migrate to inflamed sites and then differentiate into macrophages to aggra-vate arthritis. Therefore, a drug carrier that can be specifically internalized by circulating monocytes and switch monocytes into anti-inflammatory phenotype when reaching inflamed sites may achieve efficient arthritis therapy. Here, we designed a monocyte-targeting nanoparticle (ZDNP) to selectively deliver anti-inflammatory Dex to circulating monocytes. When injected intravenously, ZDNP was effectively internal-ized by circulating monocytes via a scavenger receptor and subsequently was transported to arthritic joints, where monocytes engulfing the drug-loaded nanoparticles could switch to an anti-inflammatory phenotype to inhibit arthritis progress. We provide detailed evidence about the in vivo fate of ZDNP and unravel how monocytes act as a "living drug depot" to achieve site-directed arthritis therapy.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Coordination-driven self-assembly of metallo-nanodrugs for local inflammation alleviation

A Magnesium-Based Coordination Container As a Multi-Drugs Co-Loaded System for Boosting Anti-Inflammatory Therapy in Joints

High-Efficiency Treatment for Osteoarthritis Via Self-Assembled Dual-Functionalized Nanobiologics.

Hierarchical superparamagnetic metal–organic framework nanovectors as anti-inflammatory nanomedicines

Nanoarchitectonics of Injectable Biomimetic Conjugates for Cartilage Protection and Therapy Based on Degenerative Osteoarthritis Progression

Metal–Drug Coordination Nanoparticles and Hydrogels for Enhanced Delivery

Combination of anti-inflammatory therapy and RNA interference by light-inducible hybrid nanomedicine for osteoarthritis treatment

A carrier-free nano-drug assembled via π–π stacking interaction for the treatment of osteoarthritis

Functional nano drug delivery system with dual lubrication and immune escape for treating osteoarthritis

A pH-responsive metal-organic framework for the co-delivery of HIF-2α siRNA and curcumin for enhanced therapy of osteoarthritis

Metal Ions Modulation of the Self-Assembly of Short Peptide Conjugated Nonsteroidal Anti-Inflammatory Drugs (Nsaids)

A biomimetic lubricating nanosystem for synergistic therapy of osteoarthritis

Rational design of metal-organic frameworks to deliver methotrexate for targeted rheumatoid arthritis therapy

Baicalin nanodelivery system based on functionalized metal-organic framework for targeted therapy of osteoarthritis by modulating macrophage polarization

Neutrophil-erythrocyte hybrid membrane-coated hollow copper sulfide nanoparticles for targeted and photothermal/ anti-inflammatory therapy of osteoarthritis

Inflammation-homing “living Drug Depot” for Efficient Arthritis Treatment

Multifunctional injectable microspheres for osteoarthritis therapy via spatiotemporally modulating macrophage polarization and inflammation

Cyclodextrin Cationic Polymer-Based Nanoassemblies to Manage Inflammation by Intra-Articular Delivery Strategies

Advances in local drug delivery technologies for improved rheumatoid arthritis therapy

Imidazolium-Based Ionic Liquid-Assisted Preparation of Nano-Spheres Loaded with Bio-Active Peptides to Decrease Inflammation in an Osteoarthritis Model: Ex Vivo Evaluations.

A Biomimetic Lubricating Nanosystem with Responsive Drug Release for Osteoarthritis Synergistic Therapy